Growth Metrics

Johnson & Johnson (JNJ) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $2.12.

  • Johnson & Johnson's EPS (Weighted Average and Diluted) rose 9099.1% to $2.12 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.36, marking a year-over-year increase of 7039.47%. This contributed to the annual value of $5.79 for FY2024, which is 5779.88% down from last year.
  • Latest data reveals that Johnson & Johnson reported EPS (Weighted Average and Diluted) of $2.12 as of Q3 2025, which was up 9099.1% from $2.29 recorded in Q2 2025.
  • Johnson & Johnson's 5-year EPS (Weighted Average and Diluted) high stood at $10.21 for Q4 2023, and its period low was -$0.19 during Q2 2023.
  • Over the past 5 years, Johnson & Johnson's median EPS (Weighted Average and Diluted) value was $1.68 (recorded in 2022), while the average stood at $1.94.
  • As far as peak fluctuations go, Johnson & Johnson's EPS (Weighted Average and Diluted) crashed by 12947.27% in 2023, and later soared by 444959.52% in 2024.
  • Johnson & Johnson's EPS (Weighted Average and Diluted) (Quarter) stood at $1.37 in 2021, then increased by 22.63% to $1.68 in 2022, then tumbled by 101.93% to -$0.03 in 2023, then skyrocketed by 4449.6% to $1.41 in 2024, then soared by 50.35% to $2.12 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $2.12 for Q3 2025, versus $2.29 for Q2 2025 and $4.54 for Q1 2025.